Product image of Mometasonfuroat Glenmark (Mometasone Furoate) supplied by GNH India

Mometasonfuroat Glenmark

Active Ingredient:
Mometasone Furoate
Origin:
EU

Mometasonfuroat Glenmark (Mometasone Furoate)

Mometasone Furoate, the active ingredient in Mometasonfuroat Glenmark, is a corticosteroid presented as a topical formulation for skin use. It is employed to reduce inflammation and relieve symptoms in various dermatologic conditions affecting adults and children. It is indicated for the management of chronic inflammatory dermatoses and is formulated to ensure optimal skin penetration and patient adherence.

GNH India supplies Mometasonfuroat Glenmark as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory‑approved batches to meet global demand.

Manufacturer / TM Owner

Glenmark Arzneimittel Gmbh

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Mometasone Furoate is used topically to treat inflammatory skin disorders by suppressing the underlying immune response.

  • Psoriasis: reduces plaque formation and scaling, improving skin appearance.
  • Eczema: alleviates redness, itching and swelling associated with eczema flares.
  • Atopic dermatitis: controls chronic inflammation and pruritus in affected areas.
  • Contact dermatitis: diminishes irritation caused by allergic or irritant contact.
  • Other inflammatory skin disorders: provides symptomatic relief in various dermatitis types.

How It Works

  • Mometasone Furoate binds to intracellular glucocorticoid receptors in keratinocytes and immune cells. The receptor complex translocates to the nucleus and modulates gene transcription, leading to decreased production of pro‑inflammatory cytokines, chemokines and arachidonic‑acid metabolites. This results in reduced leukocyte infiltration, edema and epidermal hyperproliferation, thereby exerting potent anti‑inflammatory and immunosuppressive effects on the skin.

Side Effects

Topical application of Mometasone Furoate may be associated with local and systemic adverse reactions.

Common Side Effects

  • Burning or stinging sensation at the application site.
  • Mild skin irritation or erythema.
  • Dryness or peeling of the treated skin.

Serious or Rare Side Effects

  • Secondary skin infections such as bacterial, fungal or viral.
  • Skin atrophy, striae or telangiectasia with prolonged use.
  • Systemic cortisol suppression leading to adrenal insufficiency.

Precautions & Warnings

Before prescribing Mometasone Furoate, clinicians should consider several safety precautions.

  • Duration of therapy: limit use to the shortest effective period to minimize skin thinning.
  • Potency: avoid use on large surface areas or under occlusion unless directed.
  • Age restrictions: use with caution in children under 2 years of age.
  • Pre‑existing infections: assess and treat any bacterial, fungal or viral skin infection before initiating therapy.
  • Systemic absorption: monitor for signs of hypothalamic‑pituitary‑adrenal axis suppression in extensive or prolonged treatment.
  • Store at ambient temperature: keep the product in the original container, protect from moisture and direct sunlight.

Avoid Interactions

Mometasone Furoate can interact with other agents that affect skin integrity or systemic corticosteroid exposure.

Major Interactions (Avoid)

  • Systemic corticosteroids: concurrent use may increase risk of systemic adrenal suppression.
  • Potent immunosuppressants (e.g., tacrolimus): may exacerbate local immunosuppression and infection risk.

Moderate Interactions (Monitor Closely)

  • Antifungal or antibacterial topical agents: may alter absorption or increase irritation.
  • Skin barrier‑disrupting products (e.g., keratolytics): could enhance systemic uptake.
  • Phototherapy: combined use may increase skin sensitivity.

Frequently Asked Questions

Mometasonfuroat Glenmark contains mometasone furoate, a potent topical corticosteroid used to treat inflammatory skin conditions such as psoriasis, eczema, atopic dermatitis, contact dermatitis and other dermatoses where reduction of redness, swelling and itching is required.

Mometasone furoate binds to glucocorticoid receptors in skin cells, altering gene transcription. This suppresses the production of inflammatory mediators, decreases leukocyte migration, and reduces epidermal hyperproliferation, providing strong anti‑inflammatory and immunosuppressive effects at the site of application.

The dosage and frequency are determined by the prescribing clinician based on the severity of the condition, the area of skin involved and patient age. Typical regimens involve applying a thin layer once or twice daily for a limited period, but the exact instructions must come from the prescriber.

Safety data for topical mometasone furoate in pregnancy and lactation are limited, and the product is classified as pregnancy category unknown. It should be used only if the potential benefit justifies any potential risk to the fetus or infant, and under close medical supervision.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any required import documentation.

Mometasone furoate is a high‑potency class II corticosteroid, offering stronger anti‑inflammatory action than low‑potency agents such as hydrocortisone but less potency than class I steroids like clobetasol. It provides a balance of efficacy and safety for moderate‑to‑severe dermatoses, often preferred when a potent yet manageable steroid is needed.

Store the product at ambient temperature, preferably below 25 °C, in its original packaging. Protect it from moisture, excessive heat and direct sunlight. Keep the container tightly closed when not in use and out of reach of children.

Apply a thin layer of the cream or ointment to the affected skin area, gently rubbing it in until fully absorbed. Follow the prescriber’s instructions regarding frequency and duration, and avoid applying to broken skin, the face or mucous membranes unless specifically directed.

Serious adverse events include secondary skin infections, skin atrophy or striae with prolonged use, and systemic effects such as adrenal suppression or Cushing‑like syndrome. Patients should be monitored for signs of infection, unusual thinning of the skin, or systemic hormonal disturbances.

The product should be avoided in individuals with known hypersensitivity to mometasone furoate or any formulation excipients. It is also contraindicated on untreated bacterial, fungal or viral skin infections, and should be used with caution in patients with severe systemic infections or uncontrolled diabetes.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Mometasone Furoate

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT